Michael Gibney

Michael Gibney
Michael Gibney

Michael Gibney is a former editor at FierceMarkets Life Sciences group.

Stories by Michael Gibney

Rust composite could make gold nanoparticles less pricey

Gold nanoparticles have many uses in drug delivery and diagnostics, but a precious metal even at the nanoscale can cost a lot to manufacture and scale up for use in research and, ultimately, biomedicine. Researchers have found, though, that a type of rust particle could have the properties needed and come at a much lower price.

Targeting tumor cells' fat synthesis cuts tumors by 87%

A group of researchers from the Salk Institute, joined by scientists from academic and industry collaborators, has demonstrated that an acetyl-CoA carboxylase, or ACC, inhibitor can shrink tumors when delivered to lung cancer cells. The inhibitor targets fat synthesis, essentially cutting off one of the tumor’s sources of growth.